Fotemustine, teniposide and dexamethasone versus high-dose methotrexate plus cytarabine in newly diagnosed primary CNS lymphoma: a randomised phase 2 trial

被引：0
|
作者：
Jingjing Wu
Lingling Duan
Lei Zhang
Zhenchang Sun
Xiaorui Fu
Xin Li
Ling Li
Xinhua Wang
Xudong Zhang
Zhaoming Li
Hui Yu
Yu Chang
Feifei Nan
Jiaqin Yan
Li Tian
Xiaoli Wang
Mingzhi Zhang
机构：
[1] The First Affiliated Hospital of Zhengzhou University,Department of Oncology, Lymphoma Diagnosis and Treatment Centre of Henan Province
来源：
Journal of Neuro-Oncology | 2018年 / 140卷
关键词：
Teniposide; Methotrexate; Primary CNS lymphoma; Chemotherapy; Whole-brain radiotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：427 / 434
页数：7
相关论文
共 50 条
  • [31] Systemic high-dose methotrexate plus ifosfamide is highly effective for central nervous system (CNS) involvement of lymphoma
    Fischer, Lars
    Korfel, Agnieszka
    Kiewe, Philipp
    Neumann, Martin
    Jahnke, Kristoph
    Thiel, Eckhard
    ANNALS OF HEMATOLOGY, 2009, 88 (02) : 133 - 139
  • [32] Stereotactic radiosurgery in combination with up-front high-dose methotrexate as a first-line treatment for newly diagnosed primary central nervous system lymphoma
    Hirono, Seiichiro
    Iwadate, Yasuo
    Higuchi, Yoshinori
    Serizawa, Toru
    Nagano, Osamu
    Matsutani, Tomoro
    Saeki, Naokatsu
    JOURNAL OF NEURO-ONCOLOGY, 2015, 123 (02) : 237 - 244
  • [33] High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial
    Thiel, Eckhard
    Korfel, Agnieszka
    Martus, Peter
    Kanz, Lothar
    Griesinger, Frank
    Rauch, Michael
    Roeth, Alexander
    Hertenstein, Bernd
    von Toll, Theda
    Hundsberger, Thomas
    Mergenthaler, Hans-Guenther
    Leithaeuser, Malte
    Birnbaum, Tobias
    Fischer, Lars
    Jahnke, Kristoph
    Herrlinger, Ulrich
    Plasswilm, Ludwig
    Naegele, Thomas
    Pietsch, Torsten
    Bamberg, Michael
    Weller, Michael
    LANCET ONCOLOGY, 2010, 11 (11) : 1036 - 1047
  • [34] High-dose methotrexate and temozolomide associated with intrathecal liposomal cytarabine for the treatment of primary or secondary central nervous system lymphoma: A preliminary experience
    Falchi, Lorenzo
    Gunnellini, Marco
    Ferranti, Lucia
    Liberati, Anna Marina
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2012, 114 (10) : 1376 - 1378
  • [35] Prognostic value of immunohistochemical profile and response to high-dose methotrexate therapy in primary CNS lymphoma
    Hiroyuki Momota
    Yoshitaka Narita
    Akiko M. Maeshima
    Yasuji Miyakita
    Aya Shinomiya
    Takashi Maruyama
    Yoshihiro Muragaki
    Soichiro Shibui
    Journal of Neuro-Oncology, 2010, 98 : 341 - 348
  • [36] Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma
    Ponzoni, M.
    Issa, S.
    Batchelor, T. T.
    Rubenstein, J. L.
    ANNALS OF ONCOLOGY, 2014, 25 (02) : 316 - 322
  • [37] Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexate
    Lurain, Kathryn
    Uldrick, Thomas S.
    Ramaswami, Ramya
    Polizzotto, Mark N.
    Goncalves, Priscila H.
    Widell, Anaida
    Steinberg, Seth M.
    Jaffe, Elaine S.
    Pittaluga, Stefania
    Wang, Hao-Wei
    Yuan, Constance M.
    Tamula, Mary Anne
    Martin, Staci
    Wolters, Pamela L.
    George, Jomy
    Little, Richard F.
    Yarchoan, Robert
    BLOOD, 2020, 136 (19) : 2229 - 2232
  • [38] Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: Results of a phase II study in newly diagnosed children
    Kellie, SJ
    Wong, CKF
    Dalla Pozza, L
    Waters, KD
    Lockwood, L
    Mauger, DC
    White, L
    MEDICAL AND PEDIATRIC ONCOLOGY, 2002, 39 (03): : 168 - 174
  • [39] Systemic high-dose methotrexate plus ifosfamide is highly effective for central nervous system (CNS) involvement of lymphoma
    Lars Fischer
    Agnieszka Korfel
    Philipp Kiewe
    Martin Neumann
    Kristoph Jahnke
    Eckhard Thiel
    Annals of Hematology, 2009, 88
  • [40] Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance
    Tatarczuch, Maciej
    Lewis, Katharine Louise
    Gunjur, Ashray
    Shaw, Briony
    Poon, Li Mei
    Paul, Erin
    Ku, Matthew
    Wong, Mark
    Ai, Sylvia
    Beekman, Ashley
    Ciaccio, Pietro R. Di
    Krigstein, Michael
    Wight, Joel
    Coombes, Caitlin
    Gilbertson, Michael
    Tey, Amanda
    Shortt, Jake
    Nagarajan, Chandramouli
    Talaulikar, Dipti
    Hamad, Nada
    Ratnasingam, Sumita
    Ho, Shir-Jing
    Cochrane, Tara
    Hawkes, Eliza A.
    Cheah, Chan Y.
    Opat, Stephen
    Gregory, Gareth P.
    EJHAEM, 2024, 5 (04): : 709 - 720
12345